Goods & Services

Beef from the Iga Region, Mie Prefecture; processed beef products from the Iga Region, Mie Prefecture. Japanese cattle from the Iga Region, Mie Prefecture.

Abstract

Disclosed is novel means that enables collection of embryos from the uterus of a living livestock animal, especially cattle, easily in a short time with the same accuracy as that achieved by a skilled technician. A livestock embryo collection apparatus of the present invention comprises: two syringes; a liquid transfer line for connecting a perfusate supply section-a syringe I-a balloon catheter-a syringe II-an embryo collection section; a liquid transfer direction control section for controlling the direction of transfer of a perfusate in the liquid transfer line; and a syringe pump control section for controlling pump operation of the two syringes. By this apparatus, injection and removal of the perfusate can be quickly carried out by simultaneous operation of the two syringes by the syringe pump control section and the liquid transfer direction control section that work in a coordinated manner, so that the working time for collection of embryos can be largely reduced, and so that embryos in the uterus of a living animal can be collected easily, quickly, and with the same accuracy as that achieved by a skilled technician.

IPC Classes  ?

• A61D 19/04 - Instruments or methods for reproduction or fertilisation for embryo transplantation
• A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems

Abstract

Disclosed is a vaccine for non-human animals, which vaccine enables effective immune induction in non-human animals such as livestock or poultry. The vaccine for non-human animals of the present invention comprises liposomes each comprising an antigen molecule(s) bound to the surface thereof, the antigen molecule(s) being derived from a pathogen infectious to the non-human animals. The non-human animals are, for example, livestock or poultry. One most preferred example of the vaccine according to the present invention is an infectious bronchitis virus (IBV) vaccine, which is effective against various isolated IBV strains, and which is expected to be sufficiently applicable even to cases where a mutant strain appeared. Another preferred example of the vaccine according to the present invention is a PRRSV vaccine, which was confirmed to have an effect that reduces fever, lung lesion development, and the like caused by the infection. The present invention enables development of liposome vaccines effective for prevention of infections caused by various non-human animal pathogens including PRRSV as well as IBV.

IPC Classes  ?

• A61K 39/385 - Haptens or antigens, bound to carriers
• A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
• A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
• A61K 39/12 - Viral antigens
• A61P 31/14 - Antivirals for RNA viruses

Abstract

The present invention relates to a laminate for a paddy rice seedling nursery, said laminate including a bed soil layer and a cover soil layer, wherein one or both of the bed soil layer and the cover soil layer is a water-absorbing resin layer that includes a particulate water-absorbing resin, the water-absorbing resin is disposed such that at least some paddy rice can come into contact with the water-absorbing resin, and the water-absorbing resin content in the laminate for a paddy rice seedling nursery is 1 to 5,000 g/m2.

IPC Classes  ?

• A01G 22/22 - Rice
• A01G 24/15 - Calcined rock, e.g. perlite, vermiculite or clay aggregates
• A01G 24/25 - Dry fruit hulls or husks, e.g. chaff or coir
• A01G 24/28 - Growth substratesCulture mediaApparatus or methods therefor based on or containing natural organic material containing peat, moss or sphagnum
• A01G 24/35 - Growth substratesCulture mediaApparatus or methods therefor based on or containing synthetic organic compounds containing water-absorbing polymers
• A01G 24/46 - Growth substratesCulture mediaApparatus or methods therefor characterised by their structure in block, mat or sheet form multi-layered
• A01G 9/02 - Receptacles, e.g. flower-pots or boxes Glasses for cultivating flowers
• A01G 9/08 - Devices for filling-up flower-potsDevices for setting plants in pots

Goods & Services

Lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; protein supplements for human consumption. Edible oils and fats; milk products; meat; eggs; seafood, not live; frozen vegetables; frozen fruits; processed meat products; processed seafood; processed vegetables; processed fruits; abura-age [pieces of fried tofu]; freeze-dried tofu pieces [Kohri-dofu]; jelly made from devils' tongue root [Konnyaku]; soya milk; tofu; natto [fermented soy beans]; processed eggs; pre-cooked curry stew; pre-cooked stew; soup mixes; dried flakes of laver for sprinkling on rice in hot water [Ochazuke-nori]; Furi-kake [dried flakes of fish, meat, vegetables or seaweed]; side-dish made of fermented soybean [Name-mono]; preserved pulses; protein milk; kimchi [fermented vegetable dish]; instant miso soup; fruit-based, vegetable-based, bean-based or nut-based snacks. Tea; coffee; cocoa; ice; confectionery; sweets; desserts [confectionery]; snacks based on cereals, rice, chocolate or pastry; bread; buns; sandwiches; hamburger sandwiches; pizzas; hot dog sandwiches; meat pies; seasonings; spices; ice cream mixes; sherbet mixes; unroasted coffee; cereal preparations; cooked rice; cooked porridge; chocolate spreads; onigiri [rice balls]; Chinese stuffed dumplings; Chinese steamed dumplings; sushi; fried balls of batter mix with small pieces of octopus [Takoyaki]; boxed lunches consisting of rice, with added meat, fish or vegetables; ravioli; yeast powder; koji [fermented malted rice]; yeast; baking powder; instant confectionery mixes; pasta sauce; by-product of rice for food [Sake lees]; rice; husked oats; husked barley; gluten prepared as foodstuff; flour; granola; rice cakes; tea-based beverages; soya sauce; honey. Non-alcoholic Carbonated beverages; soft drinks; fruit juices; vegetable juices [beverages]; beer; extracts of hops for making beer; whey beverages; protein-enriched sports beverages. Sake; shochu [spirits]; sake substitutes; shirozake [Japanese sweet rice-based mixed liquor]; Naoshi [Japanese liquor]; Japanese Shochu-based mixed liquor [Mirin]; Western liquors in general; alcoholic fruit beverages; Japanese Shochu-based beverages [Chuhai]; Chinese liquors in general; flavored liquors.

Goods & Services

Rice.

Abstract

Disclosed is a vaccine for non-human animals, which can effectively induce immunity in a non-human animal such as a farm animal and a poultry. The vaccine for non-human animals according to the present invention contains a liposome having, coupled to the surface thereof, an antigen molecule derived from a pathogen capable of affecting a non-human animal. The non-human animal is, for example, a farm animal or a poultry. An infectious bronchitis virus (IBV) vaccine, which is one of the most preferred embodiments of the vaccine of the present invention, is effective against various isolated IBV strains, and is expected to be sufficiently available in the case where a mutant strain occurs. A PRRSV vaccine, which is another preferred embodiment of the vaccine of the present invention, is confirmed to have an effect to alleviate fever due to an infection or reduce the formation of a lesion in the lung and the like. According to the present invention, it becomes possible to develop a liposome vaccine effective for the prevention of infections with pathogens for various non-human animals, such as IBV and PRRSV.

IPC Classes  ?

• A61K 39/00 - Medicinal preparations containing antigens or antibodies
• A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
• A61K 39/265 - Infectious rhinotracheitis virus
• A61K 47/69 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
• A61P 31/12 - Antivirals
• A61P 37/04 - Immunostimulants
• C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus

Goods & Services

Rice

Goods & Services

Eggs

Goods & Services

Green tea processed in Fukuoka Prefecture from Aracha [i.e., unrefined tea] produced in Yame-shi, Fukuoka Prefecture and the surrounding area [including the area adjacent to the Yame Region in Kumamoto Prefecture and Saga Prefecture] by tea manufacturers in Fukuoka Prefecture.

Goods & Services

Green tea processed from unrefined tea (aracha)

Abstract

The present invention discloses a novel means capable of producing a blood chimeric animal in which a state of retaining blood cells originating in a heterologous animal at a high percentage is sustained for a long period of time. The method for producing a non-human animal that retains blood cells originating in a heterologous animal, according to the present invention, comprises transplanting hematopoietic cells of a heterologous animal into a non-human animal, in which hematopoietic cells the function of a gene that acts on the hematopoietic system is modified, The gene that acts on the hematopoietic system is, for example, Lnk gene, When a medium to large mammal is used as a recipient, the survival rate of hematopoietic cells originating in a heterologous animal is dramatically increased such that blood chimerism of 10% or more can be maintained even in a 16 month old animal.

IPC Classes  ?

• A01K 67/027 - New or modified breeds of vertebrates
• C12N 15/09 - Recombinant DNA-technology
• C12N 5/0789 - Stem cellsMultipotent progenitor cells

Abstract

Disclosed is a novel means which makes it possible to steadily mass-produce knockout individuals even in large animals. The method of the present invention is a method for producing a non-human large mammal or fish (non-human animal) that produces gametes originating in a different individual, and comprises transplanting at least one pluripotent cell derived from a second non-human animal into an embryo derived from a first non-human animal, said embryo being at a cleavage stage and having a genome in which a function of nanos3 gene is inhibited, to prepare a chimeric embryo, and allowing said chimeric embryo to develop into an individual.

IPC Classes  ?

• A01K 67/027 - New or modified breeds of vertebrates
• C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
• A61D 19/04 - Instruments or methods for reproduction or fertilisation for embryo transplantation

Goods & Services

Rice

Goods & Services

Rice

Goods & Services

Retail store services and wholesale store services featuring meat Provision of food and beverages in restaurants

Abstract

Disclosed is a novel means capable of producing a blood chimeric animal that maintains, for a long period of time, a state in which blood cells derived from a heterologous animal such as a human are retained at a high rate even in medium- to large-sized livestock. The method for preparing a non-human animal that retains blood cells derived from a heterologous animal, according to the present invention, includes transplanting, into the non-human animal, hematopoietic cells of the heterologous animal in which the function of a gene acting on a hematopoietic system has been modified. The gene acting on a hematopoietic system is, for example, the Lnk gene. According to the method of the present invention, when a medium- to large-sized mammal such as a pig is used as a recipient, the survival rate of hematopoietic cells derived from a heterologous animal is dramatically increased such that blood chimerism of 10% or more can be maintained even in a 16 month old animal.

IPC Classes  ?

• A01K 67/0276 - Knock-out vertebrates
• C12N 5/078 - Cells from blood or from the immune system
• C12N 5/0789 - Stem cellsMultipotent progenitor cells
• C12N 5/16 - Animal cells
• C12N 15/09 - Recombinant DNA-technology
• C12Q 1/00 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions

Abstract

Disclosed is a novel means capable of producing a blood chimeric animal that maintains, for a long period of time, a state in which blood cells derived from a heterologous animal such as a human are retained at a high rate even in medium- to large-sized livestock. The method for preparing a non-human animal that retains blood cells derived from a heterologous animal, according to the present invention, includes transplanting, into the non-human animal, hematopoietic cells of the heterologous animal in which the function of a gene acting on a hematopoietic system has been modified. The gene acting on a hematopoietic system is, for example, the Lnk gene. According to the method of the present invention, when a medium- to large-sized mammal such as a pig is used as a recipient, the survival rate of hematopoietic cells derived from a heterologous animal is dramatically increased such that blood chimerism of 10% or more can be maintained even in a 16 month old animal.

IPC Classes  ?

• A01K 67/027 - New or modified breeds of vertebrates
• C12N 5/16 - Animal cells
• C12N 15/09 - Recombinant DNA-technology

Abstract

Disclosed is a novel means for making it possible to steadily mass-producing a knock-out individual even of a large animal. A method according to the present invention is a method for producing a non-human large mammal or fish (a non-human animal) each capable of producing a gamete originated from a different individual. The method comprises: transplanting at least one pluripotent cell originated from a second non-human animal into a cleavage stage embryo that is originated from a first non-human animal and has genome in which the function of nanos3 gene is inhibited, thereby preparing a chimeric embryo; and developing the chimeric embryo, thereby producing an individual. When a pluripotent cell having genome in which a desired gene is knocked out is used as the pluripotent cell originated from the second non-human animal, it becomes possible to allow the first non-human animal to produce a germ cell in which the desired gene is knocked out. By crossing non-human animals which are produced in the above-mentioned manner with each other, a knock-out non-human animal can be mass-produced easily.

IPC Classes  ?

• A01K 67/027 - New or modified breeds of vertebrates
• C12N 5/10 - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
• C12N 15/09 - Recombinant DNA-technology

Abstract

Disclosed is a novel means which enables satisfactory preservation of embryos and fertilized eggs in the non-frozen state for a longer period than conventional means, which novel means also achieves high hatching ability and a high conception rate of the embryos after the preservation. The method for preserving a mammalian embryo(s) or fertilized egg(s) of the present invention comprises immersing a mammalian embryo(s) or fertilized egg(s) in a medium containing 20 to 80% (v/v) serum and 10 to 100 mM Good's buffer, and storing the embryo(s) or fertilized egg(s) at non-freezing low temperature. The preservative solution for a mammalian embryo(s) or fertilized egg(s) of the present invention essentially consists of a medium containing 20 to 80% (v/v) serum and 10 to 100 mM Good's buffer. The Good's buffer is preferably HEPES.

IPC Classes  ?

• C12N 5/073 - Embryonic cells or tissuesFoetal cells or tissues
• A01N 1/02 - Preservation of living parts
• C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
• C12M 1/24 - Apparatus for enzymology or microbiology tube or bottle type

Abstract

An injector for injecting a fertilized ovum(ova) or a sperm(s) for artificial insemination into a uterine body, by which an injection pipe can be introduced smoothly into a uterus, is disclosed. An injector for a fertilized ovum(ova) or a sperm(s) of the invention is characterized in that it comprises a guide pipe for insertion into a uterine body, an injection pipe which is inserted into the guide pipe and has a length longer than the guide pipe, and a nozzle connected to a frontal end of the injection pipe, wherein the injection pipe comprises a flexible 1st pipe section constituting a frontal side of the injection pipe, and a 2nd pipe section being more rigid than the 1st pipe section and constituting a rear side of the injection pipe.

IPC Classes  ?

• A61D 19/02 - Instruments or methods for reproduction or fertilisation for artificial insemination
• A61D 19/04 - Instruments or methods for reproduction or fertilisation for embryo transplantation

Goods & Services

Beef.

Goods & Services

Providing of food and drink Packaged steamed rice; instant cooked rice; instant cooked rice porridge

Goods & Services

Providing of food and drink Packaged steamed rice; instant cooked rice; instant cooked rice porridge

Abstract

Disclosed is a novel means which enables the satisfactory preservation of a mammalian embryo and a mammalian fertilized egg in a non-frozen state for a longer period compared with conventional means and also enables the hatchability and the conception rate of the embryo after the preservation to be maintained at higher levels. A method for preserving a mammalian embryo or fertilized egg according to the present invention comprises: immersing the mammalian embryo or fertilized egg in a culture medium containing 20 to 80% (V/V) of serum and 10 to 100 mM of a Good's buffer; and then preserving the embryo or fertilized egg under non-freeze low-temperature conditions. A preservation solution for a mammalian embryo or fertilized egg according to the present invention is essentially composed of a culture medium containing 20 to 80% (V/V) of serum and 10 to 100 mM of a Good's buffer. The Good's buffer is preferably HEPES.

IPC Classes  ?

• C12N 5/073 - Embryonic cells or tissuesFoetal cells or tissues
• C12N 5/075 - OocytesOogonia

Abstract

Disclosed is a novel means which enables the satisfactory preservation of a mammalian embryo and a mammalian fertilized egg in a non-frozen state for a longer period compared with conventional means and also enables the hatchability and the conception rate of the embryo after the preservation to be maintained at higher levels. A method for preserving a mammalian embryo or fertilized egg according to the present invention comprises: immersing the mammalian embryo or fertilized egg in a culture medium containing 20 to 80% (V/V) of serum and 10 to 100 mM of a Good's buffer; and then preserving the embryo or fertilized egg under non-freeze low-temperature conditions. A preservation solution for a mammalian embryo or fertilized egg according to the present invention is essentially composed of a culture medium containing 20 to 80% (V/V) of serum and 10 to 100 mM of a Good's buffer. The Good's buffer is preferably HEPES.

IPC Classes  ?

• C12N 5/073 - Embryonic cells or tissuesFoetal cells or tissues
• C12N 5/075 - OocytesOogonia

Abstract

Provided is an injector for injecting a fertilized egg or sperm for artificial insemination into a uterus, the injector being capable of smoothly guiding an injection tube into the uterus. This fertilized egg or sperm injector is characterized: in comprising a guiding tube for insertion into the uterus, an injection tube that is inserted inside the guiding tube and is longer than the guiding tube, and a nozzle that is connected to the tip of the injection tube; and in the injection tube being provided with a flexible first tube section that configures the leading end of the injection tube and a second tube section that is more rigid than the first tube section and configures the base end of the injection tube.

IPC Classes  ?

• A61D 19/02 - Instruments or methods for reproduction or fertilisation for artificial insemination
• A61D 19/04 - Instruments or methods for reproduction or fertilisation for embryo transplantation
• C12M 1/00 - Apparatus for enzymology or microbiology

Abstract

Provided is an injector for injecting a fertilized egg or sperm for artificial insemination into a uterus, the injector being capable of smoothly guiding an injection tube into the uterus. This fertilized egg or sperm injector is characterized: in comprising a guiding tube for insertion into the uterus, an injection tube that is inserted inside the guiding tube and is longer than the guiding tube, and a nozzle that is connected to the tip of the injection tube; and in the injection tube being provided with a flexible first tube section that configures the leading end of the injection tube and a second tube section that is more rigid than the first tube section and configures the base end of the injection tube.

IPC Classes  ?

• A61D 19/02 - Instruments or methods for reproduction or fertilisation for artificial insemination
• A61D 19/04 - Instruments or methods for reproduction or fertilisation for embryo transplantation
• C12M 1/00 - Apparatus for enzymology or microbiology

Goods & Services

Meat

Goods & Services

Meat

Goods & Services

Beef originating from Wagyu cattle Providing of food and drink including beef originating from Wagyu cattle

Abstract

Disclosed is a herbicidal composition which is capable of sufficiently reducing the chemical damage caused by a herbicide. Specifically disclosed is a herbicidal composition which contains a herbicide and a substance that has a chemical damage reducing action. The substance having a chemical damage reducing action is a specific compound.

IPC Classes  ?

• A01N 25/32 - Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
• A01N 37/22 - Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N, e.g. carboxylic acid amides or imidesThio-analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
• A01N 43/08 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom five-membered rings with oxygen as the ring hetero atom
• A01N 43/56 - 1,2-DiazolesHydrogenated 1,2-diazoles
• A01N 43/76 - 1,3-OxazolesHydrogenated 1,3-oxazoles
• A01N 43/78 - 1,3-ThiazolesHydrogenated 1,3-thiazoles
• A01N 43/86 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms, as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
• A01N 43/90 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
• A01N 47/36 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the group N—CO—N directly attached to at least one heterocyclic ringThio-analogues thereof
• A01N 47/38 - Ureas or thioureas containing the groups N—CO—N or N—CS—N containing the group N—CO—N where at least one nitrogen atom is part of a heterocyclic ringThio-analogues thereof
• A01P 13/00 - HerbicidesAlgicides